Our exclusive on the AI giant's drug science ambitions.

Get past the headlines. Reuters brings you the bigger picture. Subscribe for $1/week.

 

One Essential Read

One Essential Read

Recommended by Kate Turton, Newsletter Editor

Anthropic quietly sets up biology lab as it ramps AI drug program

 

An Anthropic logo is displayed at Moscone Center during the Dreamforce 2026 technology summit in San Francisco. September 17, 2026. REUTERS/Carlos Barria

At the end of a week when fears of AI have gripped the public, we can exclusively reveal that Anthropic has quietly set up a laboratory to do physical biology work. 

The startup has built a wet lab, or place for physical experiments, in the San Francisco Bay Area, two people familiar with the matter said.

The reason for the lab is to push its artificial-intelligence ambitions into the world of drug science. Anthropic has said it wants to unlock treatments for rare diseases, and its biology work has gone beyond "in silico" ‌or computer evaluations.

Read our exclusive
 

Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters' website

LiveIntent Logo
AdChoices Logo
 

Reuters One Essential Read is sent three days a week. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here.

Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here.

This email includes limited tracking for Reuters to understand whether you’ve engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement.

Terms & Conditions

 

© 2026 Thomson Reuters. All rights reserved.
3 Times Square, New York, NY 10036

fb ig x